CLINICAL_TRIALS
trial_result
· 2021-05-07
Clinical Trial Update: Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo [Phase 4]
Summary
Phase 4 clinical trial evaluating the neurocognitive effects of alirocumab (Praluent) versus placebo in hypercholesterolemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2021-05-07